The global market for Nimodipine Sustained Release Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Nimodipine sustained-release tablets are calcium antagonists, used for cerebral vasospasm and sudden deafness caused by ischemic cerebrovascular disease, migraine, mild subarachnoid hemorrhage. It can reduce the pain of vascular, tension, cluster and mixed headaches, reduce the frequency of attacks, and prevent the appearance of aura symptoms.

North American market for Nimodipine Sustained Release Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Nimodipine Sustained Release Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Nimodipine Sustained Release Tablets include Bionpharma, Arbor Pharmaceuticals, Sofgen Pharmaceuticals, Pharmaceutics International, Heritage Pharmaceuticals, Bayer Vital, Wuhan HITECK Biopharmaceutical, Qilu Pharmaceutical, Yabao Pharmaceutical Group, Sihuan Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nimodipine Sustained Release Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nimodipine Sustained Release Tablets.

The Nimodipine Sustained Release Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nimodipine Sustained Release Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nimodipine Sustained Release Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nimodipine Sustained Release Tablets Market Report

Report Metric	Details
Report Name	Nimodipine Sustained Release Tablets Market
Segment by Type	30mg/Piece 60mg/Piece Others
Segment by Application	Hospital Pharmacy Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bionpharma, Arbor Pharmaceuticals, Sofgen Pharmaceuticals, Pharmaceutics International, Heritage Pharmaceuticals, Bayer Vital, Wuhan HITECK Biopharmaceutical, Qilu Pharmaceutical, Yabao Pharmaceutical Group, Sihuan Pharmaceutical, Jiangsu Kanion Pharmaceutical, Shandong Yunmen Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nimodipine Sustained Release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nimodipine Sustained Release Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Nimodipine Sustained Release Tablets Market report?

Ans: The main players in the Nimodipine Sustained Release Tablets Market are Bionpharma, Arbor Pharmaceuticals, Sofgen Pharmaceuticals, Pharmaceutics International, Heritage Pharmaceuticals, Bayer Vital, Wuhan HITECK Biopharmaceutical, Qilu Pharmaceutical, Yabao Pharmaceutical Group, Sihuan Pharmaceutical, Jiangsu Kanion Pharmaceutical, Shandong Yunmen Pharmaceutical

What are the Application segmentation covered in the Nimodipine Sustained Release Tablets Market report?

Ans: The Applications covered in the Nimodipine Sustained Release Tablets Market report are Hospital, Pharmacy, Others

What are the Type segmentation covered in the Nimodipine Sustained Release Tablets Market report?

Ans: The Types covered in the Nimodipine Sustained Release Tablets Market report are 30mg/Piece, 60mg/Piece, Others

1 Nimodipine Sustained Release Tablets Market Overview

1.1 Product Definition

1.2 Nimodipine Sustained Release Tablets by Type

1.2.1 Global Nimodipine Sustained Release Tablets Market Value Comparison by Type (2024 VS 2031)

1.2.2 30mg/Piece

1.2.3 60mg/Piece

1.2.4 Others

1.3 Nimodipine Sustained Release Tablets by Application

1.3.1 Global Nimodipine Sustained Release Tablets Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Others

1.4 Global Nimodipine Sustained Release Tablets Market Size Estimates and Forecasts

1.4.1 Global Nimodipine Sustained Release Tablets Revenue 2020-2031

1.4.2 Global Nimodipine Sustained Release Tablets Sales 2020-2031

1.4.3 Global Nimodipine Sustained Release Tablets Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Nimodipine Sustained Release Tablets Market Competition by Manufacturers

2.1 Global Nimodipine Sustained Release Tablets Sales Market Share by Manufacturers (2020-2025)

2.2 Global Nimodipine Sustained Release Tablets Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Nimodipine Sustained Release Tablets Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Nimodipine Sustained Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Nimodipine Sustained Release Tablets, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Nimodipine Sustained Release Tablets, Product Type & Application

2.7 Global Key Manufacturers of Nimodipine Sustained Release Tablets, Date of Enter into This Industry

2.8 Global Nimodipine Sustained Release Tablets Market Competitive Situation and Trends

2.8.1 Global Nimodipine Sustained Release Tablets Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Nimodipine Sustained Release Tablets Players Market Share by Revenue

2.8.3 Global Nimodipine Sustained Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Nimodipine Sustained Release Tablets Market Scenario by Region

3.1 Global Nimodipine Sustained Release Tablets Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Nimodipine Sustained Release Tablets Sales by Region: 2020-2031

3.2.1 Global Nimodipine Sustained Release Tablets Sales by Region: 2020-2025

3.2.2 Global Nimodipine Sustained Release Tablets Sales by Region: 2026-2031

3.3 Global Nimodipine Sustained Release Tablets Revenue by Region: 2020-2031

3.3.1 Global Nimodipine Sustained Release Tablets Revenue by Region: 2020-2025

3.3.2 Global Nimodipine Sustained Release Tablets Revenue by Region: 2026-2031

3.4 North America Nimodipine Sustained Release Tablets Market Facts & Figures by Country

3.4.1 North America Nimodipine Sustained Release Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Nimodipine Sustained Release Tablets Sales by Country (2020-2031)

3.4.3 North America Nimodipine Sustained Release Tablets Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Nimodipine Sustained Release Tablets Market Facts & Figures by Country

3.5.1 Europe Nimodipine Sustained Release Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Nimodipine Sustained Release Tablets Sales by Country (2020-2031)

3.5.3 Europe Nimodipine Sustained Release Tablets Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Nimodipine Sustained Release Tablets Market Facts & Figures by Region

3.6.1 Asia Pacific Nimodipine Sustained Release Tablets Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Nimodipine Sustained Release Tablets Sales by Region (2020-2031)

3.6.3 Asia Pacific Nimodipine Sustained Release Tablets Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Nimodipine Sustained Release Tablets Market Facts & Figures by Country

3.7.1 Latin America Nimodipine Sustained Release Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Nimodipine Sustained Release Tablets Sales by Country (2020-2031)

3.7.3 Latin America Nimodipine Sustained Release Tablets Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Nimodipine Sustained Release Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Nimodipine Sustained Release Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Nimodipine Sustained Release Tablets Sales by Country (2020-2031)

3.8.3 Middle East and Africa Nimodipine Sustained Release Tablets Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Nimodipine Sustained Release Tablets Sales by Type (2020-2031)

4.1.1 Global Nimodipine Sustained Release Tablets Sales by Type (2020-2025)

4.1.2 Global Nimodipine Sustained Release Tablets Sales by Type (2026-2031)

4.1.3 Global Nimodipine Sustained Release Tablets Sales Market Share by Type (2020-2031)

4.2 Global Nimodipine Sustained Release Tablets Revenue by Type (2020-2031)

4.2.1 Global Nimodipine Sustained Release Tablets Revenue by Type (2020-2025)

4.2.2 Global Nimodipine Sustained Release Tablets Revenue by Type (2026-2031)

4.2.3 Global Nimodipine Sustained Release Tablets Revenue Market Share by Type (2020-2031)

4.3 Global Nimodipine Sustained Release Tablets Price by Type (2020-2031)

5 Segment by Application

5.1 Global Nimodipine Sustained Release Tablets Sales by Application (2020-2031)

5.1.1 Global Nimodipine Sustained Release Tablets Sales by Application (2020-2025)

5.1.2 Global Nimodipine Sustained Release Tablets Sales by Application (2026-2031)

5.1.3 Global Nimodipine Sustained Release Tablets Sales Market Share by Application (2020-2031)

5.2 Global Nimodipine Sustained Release Tablets Revenue by Application (2020-2031)

5.2.1 Global Nimodipine Sustained Release Tablets Revenue by Application (2020-2025)

5.2.2 Global Nimodipine Sustained Release Tablets Revenue by Application (2026-2031)

5.2.3 Global Nimodipine Sustained Release Tablets Revenue Market Share by Application (2020-2031)

5.3 Global Nimodipine Sustained Release Tablets Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Bionpharma

6.1.1 Bionpharma Company Information

6.1.2 Bionpharma Description and Business Overview

6.1.3 Bionpharma Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Bionpharma Nimodipine Sustained Release Tablets Product Portfolio

6.1.5 Bionpharma Recent Developments/Updates

6.2 Arbor Pharmaceuticals

6.2.1 Arbor Pharmaceuticals Company Information

6.2.2 Arbor Pharmaceuticals Description and Business Overview

6.2.3 Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Product Portfolio

6.2.5 Arbor Pharmaceuticals Recent Developments/Updates

6.3 Sofgen Pharmaceuticals

6.3.1 Sofgen Pharmaceuticals Company Information

6.3.2 Sofgen Pharmaceuticals Description and Business Overview

6.3.3 Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Product Portfolio

6.3.5 Sofgen Pharmaceuticals Recent Developments/Updates

6.4 Pharmaceutics International

6.4.1 Pharmaceutics International Company Information

6.4.2 Pharmaceutics International Description and Business Overview

6.4.3 Pharmaceutics International Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Pharmaceutics International Nimodipine Sustained Release Tablets Product Portfolio

6.4.5 Pharmaceutics International Recent Developments/Updates

6.5 Heritage Pharmaceuticals

6.5.1 Heritage Pharmaceuticals Company Information

6.5.2 Heritage Pharmaceuticals Description and Business Overview

6.5.3 Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Product Portfolio

6.5.5 Heritage Pharmaceuticals Recent Developments/Updates

6.6 Bayer Vital

6.6.1 Bayer Vital Company Information

6.6.2 Bayer Vital Description and Business Overview

6.6.3 Bayer Vital Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Bayer Vital Nimodipine Sustained Release Tablets Product Portfolio

6.6.5 Bayer Vital Recent Developments/Updates

6.7 Wuhan HITECK Biopharmaceutical

6.7.1 Wuhan HITECK Biopharmaceutical Company Information

6.7.2 Wuhan HITECK Biopharmaceutical Description and Business Overview

6.7.3 Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Product Portfolio

6.7.5 Wuhan HITECK Biopharmaceutical Recent Developments/Updates

6.8 Qilu Pharmaceutical

6.8.1 Qilu Pharmaceutical Company Information

6.8.2 Qilu Pharmaceutical Description and Business Overview

6.8.3 Qilu Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Qilu Pharmaceutical Nimodipine Sustained Release Tablets Product Portfolio

6.8.5 Qilu Pharmaceutical Recent Developments/Updates

6.9 Yabao Pharmaceutical Group

6.9.1 Yabao Pharmaceutical Group Company Information

6.9.2 Yabao Pharmaceutical Group Description and Business Overview

6.9.3 Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Product Portfolio

6.9.5 Yabao Pharmaceutical Group Recent Developments/Updates

6.10 Sihuan Pharmaceutical

6.10.1 Sihuan Pharmaceutical Company Information

6.10.2 Sihuan Pharmaceutical Description and Business Overview

6.10.3 Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Product Portfolio

6.10.5 Sihuan Pharmaceutical Recent Developments/Updates

6.11 Jiangsu Kanion Pharmaceutical

6.11.1 Jiangsu Kanion Pharmaceutical Company Information

6.11.2 Jiangsu Kanion Pharmaceutical Description and Business Overview

6.11.3 Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Product Portfolio

6.11.5 Jiangsu Kanion Pharmaceutical Recent Developments/Updates

6.12 Shandong Yunmen Pharmaceutical

6.12.1 Shandong Yunmen Pharmaceutical Company Information

6.12.2 Shandong Yunmen Pharmaceutical Description and Business Overview

6.12.3 Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Product Portfolio

6.12.5 Shandong Yunmen Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Nimodipine Sustained Release Tablets Industry Chain Analysis

7.2 Nimodipine Sustained Release Tablets Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Nimodipine Sustained Release Tablets Production Mode & Process Analysis

7.4 Nimodipine Sustained Release Tablets Sales and Marketing

7.4.1 Nimodipine Sustained Release Tablets Sales Channels

7.4.2 Nimodipine Sustained Release Tablets Distributors

7.5 Nimodipine Sustained Release Tablets Customer Analysis

8 Nimodipine Sustained Release Tablets Market Dynamics

8.1 Nimodipine Sustained Release Tablets Industry Trends

8.2 Nimodipine Sustained Release Tablets Market Drivers

8.3 Nimodipine Sustained Release Tablets Market Challenges

8.4 Nimodipine Sustained Release Tablets Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bionpharma

Arbor Pharmaceuticals

SOFGEN PHARMACEUTICALS

Pharmaceutics International

Heritage Pharmaceuticals

Bayer Vital

Wuhan HITECK Biopharmaceutical

Qilu Pharmaceutical

Yabao Pharmaceutical Group

Sihuan Pharmaceutical

Jiangsu Kanion Pharmaceutical

Shandong Yunmen Pharmaceutical

List of Tables

Table 1. Global Nimodipine Sustained Release Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Nimodipine Sustained Release Tablets Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Nimodipine Sustained Release Tablets Market Competitive Situation by Manufacturers in 2024

Table 4. Global Nimodipine Sustained Release Tablets Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Nimodipine Sustained Release Tablets Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Nimodipine Sustained Release Tablets Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Nimodipine Sustained Release Tablets Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Nimodipine Sustained Release Tablets Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Nimodipine Sustained Release Tablets, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Nimodipine Sustained Release Tablets, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Nimodipine Sustained Release Tablets, Product Type & Application

Table 12. Global Key Manufacturers of Nimodipine Sustained Release Tablets, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Nimodipine Sustained Release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nimodipine Sustained Release Tablets as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Nimodipine Sustained Release Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Nimodipine Sustained Release Tablets Sales by Region (2020-2025) & (K Units)

Table 18. Global Nimodipine Sustained Release Tablets Sales Market Share by Region (2020-2025)

Table 19. Global Nimodipine Sustained Release Tablets Sales by Region (2026-2031) & (K Units)

Table 20. Global Nimodipine Sustained Release Tablets Sales Market Share by Region (2026-2031)

Table 21. Global Nimodipine Sustained Release Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Nimodipine Sustained Release Tablets Revenue Market Share by Region (2020-2025)

Table 23. Global Nimodipine Sustained Release Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Nimodipine Sustained Release Tablets Revenue Market Share by Region (2026-2031)

Table 25. North America Nimodipine Sustained Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Nimodipine Sustained Release Tablets Sales by Country (2020-2025) & (K Units)

Table 27. North America Nimodipine Sustained Release Tablets Sales by Country (2026-2031) & (K Units)

Table 28. North America Nimodipine Sustained Release Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Nimodipine Sustained Release Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Nimodipine Sustained Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Nimodipine Sustained Release Tablets Sales by Country (2020-2025) & (K Units)

Table 32. Europe Nimodipine Sustained Release Tablets Sales by Country (2026-2031) & (K Units)

Table 33. Europe Nimodipine Sustained Release Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Nimodipine Sustained Release Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Nimodipine Sustained Release Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Nimodipine Sustained Release Tablets Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Nimodipine Sustained Release Tablets Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Nimodipine Sustained Release Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Nimodipine Sustained Release Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Nimodipine Sustained Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Nimodipine Sustained Release Tablets Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Nimodipine Sustained Release Tablets Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Nimodipine Sustained Release Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Nimodipine Sustained Release Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Nimodipine Sustained Release Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Nimodipine Sustained Release Tablets Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Nimodipine Sustained Release Tablets Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Nimodipine Sustained Release Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Nimodipine Sustained Release Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Nimodipine Sustained Release Tablets Sales (K Units) by Type (2020-2025)

Table 51. Global Nimodipine Sustained Release Tablets Sales (K Units) by Type (2026-2031)

Table 52. Global Nimodipine Sustained Release Tablets Sales Market Share by Type (2020-2025)

Table 53. Global Nimodipine Sustained Release Tablets Sales Market Share by Type (2026-2031)

Table 54. Global Nimodipine Sustained Release Tablets Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Nimodipine Sustained Release Tablets Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Nimodipine Sustained Release Tablets Revenue Market Share by Type (2020-2025)

Table 57. Global Nimodipine Sustained Release Tablets Revenue Market Share by Type (2026-2031)

Table 58. Global Nimodipine Sustained Release Tablets Price (USD/Unit) by Type (2020-2025)

Table 59. Global Nimodipine Sustained Release Tablets Price (USD/Unit) by Type (2026-2031)

Table 60. Global Nimodipine Sustained Release Tablets Sales (K Units) by Application (2020-2025)

Table 61. Global Nimodipine Sustained Release Tablets Sales (K Units) by Application (2026-2031)

Table 62. Global Nimodipine Sustained Release Tablets Sales Market Share by Application (2020-2025)

Table 63. Global Nimodipine Sustained Release Tablets Sales Market Share by Application (2026-2031)

Table 64. Global Nimodipine Sustained Release Tablets Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Nimodipine Sustained Release Tablets Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Nimodipine Sustained Release Tablets Revenue Market Share by Application (2020-2025)

Table 67. Global Nimodipine Sustained Release Tablets Revenue Market Share by Application (2026-2031)

Table 68. Global Nimodipine Sustained Release Tablets Price (USD/Unit) by Application (2020-2025)

Table 69. Global Nimodipine Sustained Release Tablets Price (USD/Unit) by Application (2026-2031)

Table 70. Bionpharma Company Information

Table 71. Bionpharma Description and Business Overview

Table 72. Bionpharma Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Bionpharma Nimodipine Sustained Release Tablets Product

Table 74. Bionpharma Recent Developments/Updates

Table 75. Arbor Pharmaceuticals Company Information

Table 76. Arbor Pharmaceuticals Description and Business Overview

Table 77. Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Product

Table 79. Arbor Pharmaceuticals Recent Developments/Updates

Table 80. Sofgen Pharmaceuticals Company Information

Table 81. Sofgen Pharmaceuticals Description and Business Overview

Table 82. Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Product

Table 84. Sofgen Pharmaceuticals Recent Developments/Updates

Table 85. Pharmaceutics International Company Information

Table 86. Pharmaceutics International Description and Business Overview

Table 87. Pharmaceutics International Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Pharmaceutics International Nimodipine Sustained Release Tablets Product

Table 89. Pharmaceutics International Recent Developments/Updates

Table 90. Heritage Pharmaceuticals Company Information

Table 91. Heritage Pharmaceuticals Description and Business Overview

Table 92. Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Product

Table 94. Heritage Pharmaceuticals Recent Developments/Updates

Table 95. Bayer Vital Company Information

Table 96. Bayer Vital Description and Business Overview

Table 97. Bayer Vital Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Bayer Vital Nimodipine Sustained Release Tablets Product

Table 99. Bayer Vital Recent Developments/Updates

Table 100. Wuhan HITECK Biopharmaceutical Company Information

Table 101. Wuhan HITECK Biopharmaceutical Description and Business Overview

Table 102. Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Product

Table 104. Wuhan HITECK Biopharmaceutical Recent Developments/Updates

Table 105. Qilu Pharmaceutical Company Information

Table 106. Qilu Pharmaceutical Description and Business Overview

Table 107. Qilu Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Qilu Pharmaceutical Nimodipine Sustained Release Tablets Product

Table 109. Qilu Pharmaceutical Recent Developments/Updates

Table 110. Yabao Pharmaceutical Group Company Information

Table 111. Yabao Pharmaceutical Group Description and Business Overview

Table 112. Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Product

Table 114. Yabao Pharmaceutical Group Recent Developments/Updates

Table 115. Sihuan Pharmaceutical Company Information

Table 116. Sihuan Pharmaceutical Description and Business Overview

Table 117. Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Product

Table 119. Sihuan Pharmaceutical Recent Developments/Updates

Table 120. Jiangsu Kanion Pharmaceutical Company Information

Table 121. Jiangsu Kanion Pharmaceutical Description and Business Overview

Table 122. Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Product

Table 124. Jiangsu Kanion Pharmaceutical Recent Developments/Updates

Table 125. Shandong Yunmen Pharmaceutical Company Information

Table 126. Shandong Yunmen Pharmaceutical Description and Business Overview

Table 127. Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Product

Table 129. Shandong Yunmen Pharmaceutical Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Nimodipine Sustained Release Tablets Distributors List

Table 133. Nimodipine Sustained Release Tablets Customers List

Table 134. Nimodipine Sustained Release Tablets Market Trends

Table 135. Nimodipine Sustained Release Tablets Market Drivers

Table 136. Nimodipine Sustained Release Tablets Market Challenges

Table 137. Nimodipine Sustained Release Tablets Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Product Picture of Nimodipine Sustained Release Tablets

Figure 2. Global Nimodipine Sustained Release Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nimodipine Sustained Release Tablets Market Share by Type: 2024 & 2031

Figure 4. 30mg/Piece Product Picture

Figure 5. 60mg/Piece Product Picture

Figure 6. Others Product Picture

Figure 7. Global Nimodipine Sustained Release Tablets Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Nimodipine Sustained Release Tablets Market Share by Application: 2024 & 2031

Figure 9. Hospital

Figure 10. Pharmacy

Figure 11. Others

Figure 12. Global Nimodipine Sustained Release Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Nimodipine Sustained Release Tablets Market Size (2020-2031) & (US$ Million)

Figure 14. Global Nimodipine Sustained Release Tablets Sales (2020-2031) & (K Units)

Figure 15. Global Nimodipine Sustained Release Tablets Average Price (USD/Unit) & (2020-2031)

Figure 16. Nimodipine Sustained Release Tablets Report Years Considered

Figure 17. Nimodipine Sustained Release Tablets Sales Share by Manufacturers in 2024

Figure 18. Global Nimodipine Sustained Release Tablets Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Nimodipine Sustained Release Tablets Players: Market Share by Revenue in Nimodipine Sustained Release Tablets in 2024

Figure 20. Nimodipine Sustained Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Nimodipine Sustained Release Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Nimodipine Sustained Release Tablets Sales Market Share by Country (2020-2031)

Figure 23. North America Nimodipine Sustained Release Tablets Revenue Market Share by Country (2020-2031)

Figure 24. United States Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Nimodipine Sustained Release Tablets Sales Market Share by Country (2020-2031)

Figure 27. Europe Nimodipine Sustained Release Tablets Revenue Market Share by Country (2020-2031)

Figure 28. Germany Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Nimodipine Sustained Release Tablets Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Nimodipine Sustained Release Tablets Revenue Market Share by Region (2020-2031)

Figure 35. China Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Nimodipine Sustained Release Tablets Sales Market Share by Country (2020-2031)

Figure 45. Latin America Nimodipine Sustained Release Tablets Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Nimodipine Sustained Release Tablets Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Nimodipine Sustained Release Tablets Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Nimodipine Sustained Release Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Nimodipine Sustained Release Tablets by Type (2020-2031)

Figure 55. Global Revenue Market Share of Nimodipine Sustained Release Tablets by Type (2020-2031)

Figure 56. Global Nimodipine Sustained Release Tablets Price (USD/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Nimodipine Sustained Release Tablets by Application (2020-2031)

Figure 58. Global Revenue Market Share of Nimodipine Sustained Release Tablets by Application (2020-2031)

Figure 59. Global Nimodipine Sustained Release Tablets Price (USD/Unit) by Application (2020-2031)

Figure 60. Nimodipine Sustained Release Tablets Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions